Quarterly report · Q2

Period2023-01-21 → 2023-07-20
Filed2023-09-01
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥101.7bn2023-01-21 → 2023-07-20Cons.Net sales
Revenue¥160.1bn2022-01-21 → 2023-01-20Cons.Net sales (5-year summary)
Revenue¥79.8bn2022-01-21 → 2022-07-20Cons.Net sales
Operating income¥2.5bn2023-01-21 → 2023-07-20Cons.Operating income
Operating income¥723m2022-01-21 → 2022-07-20Cons.Operating income
Ordinary income¥1.8bn2023-01-21 → 2023-07-20Cons.Ordinary income
Ordinary income¥591m2022-01-21 → 2023-01-20Cons.Ordinary income loss (5-year summary)
Ordinary income¥461m2022-01-21 → 2022-07-20Cons.Ordinary income
Profit before tax¥4.1bn2023-01-21 → 2023-07-20Cons.Income before income taxes
Profit before tax¥351m2022-01-21 → 2022-07-20Cons.Income before income taxes
Net income (owners)¥2.3bn2023-01-21 → 2023-07-20Cons.Profit loss attributable to owners of parent
Net income (owners)−¥507m2022-01-21 → 2023-01-20Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥869m2022-01-21 → 2022-07-20Cons.Profit loss attributable to owners of parent
Net income¥2.4bn2023-01-21 → 2023-07-20Cons.Profit loss
Net income−¥909m2022-01-21 → 2022-07-20Cons.Profit loss
Total assets¥182.1bnat 2023-07-20Cons.Assets
Total assets¥164.2bnat 2023-01-20Cons.Assets
Total assets¥170.3bnat 2022-07-20Cons.Total assets (5-year summary)
Total liabilities¥94.3bnat 2023-07-20Cons.Liabilities
Total liabilities¥80.1bnat 2023-01-20Cons.Liabilities
Net assets / equity¥87.8bnat 2023-07-20Cons.Net assets
Net assets / equity¥84.1bnat 2023-01-20Cons.Net assets
Net assets / equity¥84.3bnat 2022-07-20Cons.Net assets (5-year summary)
Cash and deposits¥30.0bnat 2023-07-20Cons.Cash and deposits
Cash and deposits¥27.2bnat 2023-01-20Cons.Cash and deposits
Cash & equivalents¥33.0bnat 2023-07-20Cons.Cash and cash equivalents
Cash & equivalents¥29.2bnat 2023-01-20Cons.Cash and cash equivalents
Cash & equivalents¥28.8bnat 2022-07-20Cons.Cash and cash equivalents
Cash & equivalents¥30.1bnat 2022-01-20dCons.Cash and cash equivalents
Operating cash flow¥2.7bn2023-01-21 → 2023-07-20Cons.Net cash provided by used in operating activities
Operating cash flow¥5.1bn2022-01-21 → 2023-01-20Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥423m2022-01-21 → 2022-07-20Cons.Net cash provided by used in operating activities
Investing cash flow¥1.4bn2023-01-21 → 2023-07-20Cons.Net cash provided by used in investment activities
Investing cash flow−¥5.0bn2022-01-21 → 2023-01-20Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.8bn2022-01-21 → 2022-07-20Cons.Net cash provided by used in investment activities
Financing cash flow−¥50m2023-01-21 → 2023-07-20Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.1bn2022-01-21 → 2023-01-20Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.7bn2022-01-21 → 2022-07-20Cons.Net cash provided by used in financing activities
EPS (basic)¥149.292023-01-21 → 2023-07-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥168.122023-04-21 → 2023-07-20dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-32.42022-01-21 → 2023-01-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-55.542022-01-21 → 2022-07-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-0.772022-04-21 → 2022-07-20dCons.Basic earnings loss per share (5-year summary)
Equity ratio47.2%at 2023-07-20Cons.Equity to asset ratio (5-year summary)
Equity ratio50.9%at 2023-01-20Cons.Equity to asset ratio (5-year summary)
Equity ratio49.3%at 2022-07-20Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-01-21 → 2023-07-20−¥204m
Reconciling Itemsreconcilingrevenue intersegment2023-01-21 → 2023-07-20−¥204m
Reconciling Itemsreconcilingsegment profit2023-01-21 → 2023-07-20−¥502m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥74.3bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥74.2bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥19m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥1.8bn
jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segmentsegment profit2023-01-21 → 2023-07-20−¥296m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥3m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥776m
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥10.5bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥10.5bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥462m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥6.4bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥6.2bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥180m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥239m
—segment totalrevenue2023-01-21 → 2023-07-20¥102.0bn
—segment totalrevenue external2023-01-21 → 2023-07-20¥101.7bn
—segment totalrevenue intersegment2023-01-21 → 2023-07-20¥204m
—segment totalsegment profit2023-01-21 → 2023-07-20¥3.0bn
Reconciling Itemsreconcilingrevenue2022-01-21 → 2022-07-20−¥302m
Reconciling Itemsreconcilingrevenue intersegment2022-01-21 → 2022-07-20−¥302m
Reconciling Itemsreconcilingsegment profit2022-01-21 → 2022-07-20−¥615m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue2022-01-21 → 2022-07-20¥54.0bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-07-20¥54.0bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2022-01-21 → 2022-07-20¥21m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-07-20¥1.4bn
jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segmentsegment profit2022-01-21 → 2022-07-20−¥269m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue2022-01-21 → 2022-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue external2022-01-21 → 2022-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue intersegment2022-01-21 → 2022-07-20¥4m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentsegment profit2022-01-21 → 2022-07-20¥908m
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue2022-01-21 → 2022-07-20¥9.3bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-07-20¥9.3bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-07-20−¥735m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2022-01-21 → 2022-07-20¥6.0bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2022-01-21 → 2022-07-20¥5.7bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2022-01-21 → 2022-07-20¥276m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2022-01-21 → 2022-07-20¥66m
—segment totalrevenue2022-01-21 → 2022-07-20¥80.1bn
—segment totalrevenue external2022-01-21 → 2022-07-20¥79.8bn
—segment totalrevenue intersegment2022-01-21 → 2022-07-20¥302m
—segment totalsegment profit2022-01-21 → 2022-07-20¥1.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 564
ItemContextValueUnit
Income taxesCurrentYTDDuration1729000000JPY
Profit lossPrior1YTDDuration-909000000JPY
Profit lossCurrentYTDDuration2408000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-39000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration65000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration-869000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration2343000000JPY
Profit lossPrior1YTDDuration-909000000JPY
Profit lossCurrentYTDDuration2408000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-1063000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-455000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration757000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration-106000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration5230000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration-369000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-100000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-51000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration0JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration-0JPY
Other comprehensive incomePrior1YTDDuration4824000000JPY
Other comprehensive incomeCurrentYTDDuration-984000000JPY
Comprehensive incomePrior1YTDDuration3915000000JPY
Comprehensive incomeCurrentYTDDuration1424000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration3953000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration1360000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-38000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration64000000JPY
Income before income taxesPrior1YTDDuration351000000JPY
Income before income taxesCurrentYTDDuration4138000000JPY
Depreciation and amortization ope cfPrior1YTDDuration3787000000JPY
Depreciation and amortization ope cfCurrentYTDDuration4238000000JPY
Amortization of goodwill ope cfPrior1YTDDuration149000000JPY
Amortization of goodwill ope cfCurrentYTDDuration200000000JPY
Increase decrease in provision for directors retirement benefits ope cfPrior1YTDDuration2000000JPY
Increase decrease in provision for directors retirement benefits ope cfCurrentYTDDuration-162000000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration11000000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration6000000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration166000000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration202000000JPY
Increase decrease in provision for share based remuneration for directors and other officers ope cfPrior1YTDDuration-0JPY
Increase decrease in provision for share based remuneration for directors and other officers ope cfCurrentYTDDuration-4000000JPY
Increase decrease in provision for directors bonuses ope cfPrior1YTDDuration21000000JPY
Increase decrease in provision for directors bonuses ope cfCurrentYTDDuration10000000JPY
Interest and dividends income ope cfPrior1YTDDuration-61000000JPY
Interest and dividends income ope cfCurrentYTDDuration-147000000JPY
Interest expenses ope cfPrior1YTDDuration106000000JPY
Interest expenses ope cfCurrentYTDDuration217000000JPY
Equity in earnings losses of affiliates ope cfPrior1YTDDuration17000000JPY
Equity in earnings losses of affiliates ope cfCurrentYTDDuration14000000JPY
Loss on disaster ope cfPrior1YTDDuration59000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-01-20pass
balance sheet identityconsolidated 2023-07-20pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-01-20pass
statement vs summary · net assetsconsolidated 2023-07-20pass
statement vs summary · net income attributable to parentconsolidated 2022-01-21/2022-07-20pass
statement vs summary · net income attributable to parentconsolidated 2023-01-21/2023-07-20pass
statement vs summary · operating cash flowconsolidated 2022-01-21/2022-07-20pass
statement vs summary · operating cash flowconsolidated 2023-01-21/2023-07-20pass
statement vs summary · revenueconsolidated 2022-01-21/2022-07-20pass
statement vs summary · revenueconsolidated 2023-01-21/2023-07-20pass
statement vs summary · total assetsconsolidated 2023-01-20pass
statement vs summary · total assetsconsolidated 2023-07-20pass